Evidence map›Paper›PMID 33025552›Full record

ArticleJournal of endocrinological investigation2021

Analysis of metabolomics profile in hypothyroid patients before and after thyroid hormone replacement.

C Piras, M Pibiri, V P Leoni, A Balsamo, L Tronci, N Arisci, S Mariotti, L Atzori

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of endocrinological investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Myoinositol in Autoimmune Thyroiditis.Frontiers in endocrinology · 2022
    Review
  14. A SERS Platform for Rapid Detection of Drug Resistance of Non-International journal of nanomedicine · 2022
    Article
  15. Review
  16. The Influence of Oxidative Stress on Thyroid Diseases.Antioxidants (Basel, Switzerland) · 2021
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

C PirasDepartment of Biomedical Sciences, University of Cagliari, 09042, Monserrato, Italy.
M PibiriDepartment of Biomedical Sciences, University of Cagliari, 09042, Monserrato, Italy.
V P LeoniDepartment of Biomedical Sciences, University of Cagliari, 09042, Monserrato, Italy.
A BalsamoDepartment of Biomedical Sciences, University of Cagliari, 09042, Monserrato, Italy.
L TronciDepartment of Biomedical Sciences, University of Cagliari, 09042, Monserrato, Italy.
N ArisciDepartment of Medical Sciences and Public Health, University of Cagliari, 09042, Monserrato, Italy.
S MariottiDepartment of Medical Sciences and Public Health, University of Cagliari, 09042, Monserrato, Italy. mariottistefano48@gmail.com.ORCID http://orcid.org/0000-0002-1208-7057
L AtzoriDepartment of Biomedical Sciences, University of Cagliari, 09042, Monserrato, Italy.
University of Cagliari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe serum metabolic changes occurring during the transition from hypothyroidism to euthyroidism are not known. This study aimed to determine the metabolomic profile in hypothyroid patients before (HypoT

methodsEighteen patients with overt primary hypothyroidism were recruited for the study. All patients were treated with L-T4 to achieve euthyroidism. Thyrotropin (TSH), free thyroxine (FT4), free triiodothyronine (FT3) and metabolomics profiles were measured before and after 3 months of treatment. The euthyroid control group consisted of 28 healthy volunteers. Metabolomics analysis was performed using Nuclear Magnetic Resonance (NMR) spectroscopy.

results

conclusionThese results suggest that metabolic changes in the patients with hypothyroidism may persist after normalization of serum levels of FT3, FT4, and TSH, which currently represent the gold standard in laboratory testing for diagnosis and evaluation of thyroid pathology. So, the metabolomics approach may contribute to integrate classical hormone assays and to determine the euthyroid status achievement with greater efficacy.

Indexed as

HypothyroidismThyroid GlandThyroxineBiomarkersDrug MonitoringFemaleHormone Replacement TherapyHumansLongitudinal StudiesMaleMetabolomeMetabolomicsMiddle AgedThyroid Function TestsThyrotropinTriiodothyronineBiomarkersThyrotropinThyroxineTriiodothyronine1H NMRBiomarkersHypothyroidismMetabolomicsMultivariate statistical analysis

Identifiers

PMID33025552
OpenAlexW3092329888

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.